exponential growth, page-2

Biota was the brains and GSK was the backing that brought the world Relenza.

They both thought the world would recognise the advantage of an inhaled (and injectable) antiviral designed purely to defeat influenza, over (in order of importance to Gilead/Roche)an antiviral easy to take (swallow), designed to work around BTA patents, that could be fast-tracked into production, that was invented in the only country that counts (America), and defeats most influenza strains.


However I think your timing is correct because Tamiflu resistance is an immediate threat that can no longer be ignored.

P.S. In the thirty+ years it's taken to reach this moment in time Biota's brains have turned to pampered mush (hat tip to Peter our CEO), GSK decided it was all too hard and backed vaccines instead, but more importantly, NO RESISTANT VIRUS has yet been isolated from a Relenza-treated immunocompetent patient.